2020
DOI: 10.1016/j.tjog.2020.01.007
|View full text |Cite
|
Sign up to set email alerts
|

Serum Caspase-1 levels in women with polycystic ovary syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 25 publications
0
4
0
Order By: Relevance
“…21 According to Umit Cabus' study, serum IL-10 levels were greater in study participants than in controls, and the LH/FSH ratio was noticeably higher in PCOS-affected women. 22 When compared to controls, PCOS patients' mean plasma concentration of IL10 was significantly lower, and it had no effect on the levels of FSH, LH, or PRL. 23 Hyperinsulinemia stimulates the pituitary's reaction to gonadotropin-releasing hormone (GnRH), which increases the release of luteinizing hormone and androgen.…”
Section: Discussionmentioning
confidence: 86%
“…21 According to Umit Cabus' study, serum IL-10 levels were greater in study participants than in controls, and the LH/FSH ratio was noticeably higher in PCOS-affected women. 22 When compared to controls, PCOS patients' mean plasma concentration of IL10 was significantly lower, and it had no effect on the levels of FSH, LH, or PRL. 23 Hyperinsulinemia stimulates the pituitary's reaction to gonadotropin-releasing hormone (GnRH), which increases the release of luteinizing hormone and androgen.…”
Section: Discussionmentioning
confidence: 86%
“…4 Among these, polycystic ovary syndrome may be one of best examples. [5][6][7] In their study, this hypothesis seems to be supported by their study, since according to the significant increase of LDL-C and decrease HDL-C in transmen treated with androgen, the authors concluded this androgen-related change of lipid profile may increase the CVD risk in transmen. 1 We do not want to argue this conclusion.…”
mentioning
confidence: 73%
“…Tshori et al [161], Cheng et al [162], Nowzari et al [163], Choi et al [164], Ji et al [165], Huang et al [166], Zhai et al [167], Schiattarella et al [168], Brodehl et al [169], Wu et al [170], Zhao et al [171], Ujihara et al [172], Tan et al [173], Gittleman et al [174], Chen et al [175], Layrisse et al [176], Nakayama et al [177], Zhang et al [178], Vadvalkar et al [179], Burdon et al [180], Steffen et al [181], Ye et al [182], Tao et al [183] and Li et al [184] reported that PLA2G5, CASP1, TNNT2, FOXP3, DRD4, NEURL1, TIMP4, SOCS1, CD74, PLK1, ATF5, GATA6, IRF7, FOXC2, IRF9, FHOD3, BGN (biglycan), CACNA1H, FBLN2, ADAMTS8, COL1A1, POSTN (periostin), VARS2, SOD3, ADAMTS13, FABP5, ADAM23, COL1A2, MST1, ENDOG (endonuclease G), NKX2-6, MYOCD (myocardin), CES1, CYP19A1, PKP2, CD36, SALL1, ARG1, MSR1, S1PR1, OXTR (oxytocin receptor), MITF (melanocyte inducing transcription factor), MSX2, LEPR (leptin receptor), CDH13, PRKCH (protein kinase C eta), AR (androgen receptor), DKK3, FOXO1, CRYAB (crystallin alpha B), B2M, WWP1, FKTN (fukutin), PIK3C2A, KLKB1, CHRNA5, HLA-C, ARRDC4, KCNE3, MPC2, EPHX2, C2, IKZF2, ZBTB20 and RCN2 expressions might be regarded as an indicator of susceptibility to cardiovascular problems. CASP1 [185], FOXP3 [186], SOCS1 [187], GATA6 [188], IRF7 [189], POSTN (periostin) [190], CYP19A1 [191], CD36 [192], LYN (LYN proto-oncogene, Src family tyrosine kinase) [193], CD4 [194], LEPR (leptin receptor) [195], AR (androgen receptor) [196], FOXO1 [197] and PON2 [198] are a potential biomarkers for the detection and prognosis of PCOS. Udjus et al [199] Benjafield et al [200], Shetty et al [58], Kassan et al [201], Wetzl et al [202], Le Hiress et al [203], Pal-Ghosh et al [204], Niu, [205], Fan et al [206], Deng et al [207], Chen et al [208], Sardo et al [209], Seidel et al [210], Zhu et al [211], Omura et al [212], Hu et al [213], Castoldi et al [214], Yoshida et al [215], Palao et al [216…”
Section: Discussionmentioning
confidence: 99%